51 stories
Exuberance interrupted
IPO window shuts for two Massachusetts biotech companies
(Map graphic courtesy of Boston.com)

Ten Massachusetts biotech companies have gone public so far in 2014, a record number for any one year. But the next two contenders in line— who were expected to complete initial public offerings this week — did not make it through the IPO window amid an apparent glut of biotech IPO supply nationally.

Read More